Geneva Partners, LLC
•CIK: 1712671•Filing: Q4 2025
**Geneva Partners, LLC** manages $281M across a diversified portfolio of 69 positions. The fund exhibits significant concentration in technology and healthcare leaders, notably holding GOOGL ($18.2M), LLY ($16.9M), and NVDA ($16.6M). Further substantial allocations include AVGO ($15.1M), GQ9 ($14.6M), and MSFT ($12.1M). This positioning suggests a conviction in high-growth, market-leading technology and pharmaceutical sectors.
Total AUM
$280.8M
QoQ Performance
+2.6%
Positions
56
Top 10 Concentration
49.4%
Latest Filing
Q4 2025
Top Holdings Allocation
GOOGL
LLY
NVDA
AVGO
GQ9
GOOGL6.5%
LLY6.0%
NVDA5.9%
AVGO5.4%
GQ95.2%
MSFT4.3%
META4.2%
IVV4.2%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other53.6%
Technology26.4%
Healthcare6.0%
ETF5.1%
Consumer5.1%
Financial2.5%
Communication0.9%
Industrial0.2%
🚪 Exited Positionssold since Q3 2025
+9 more exited positions
Changes from Q3 2025
NEW15 new positions
↑25 increased
↓25 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023